CTMX
CytomX Therapeutics, Inc.stockNASDAQ
Market OpenNov 19, 2026 9:53:17 AM EST
1.91USD+1.596%(+0.03)297,573
Pre-marketNov 19, 2026 9:26:30 AM EST
1.9107USD+1.633%(+0.0307)
CTMX Financials
In Q3 FY 2026 (ended ), CytomX Therapeutics, Inc. (CTMX) reported revenue of $1.69M, net income of −$20M, operating cash flow of $16.65M, and assets of $364.68M (filed ).
Loading business breakdowns…
